drugset / Trial / NCT01359501

Evaluation of the Effects of Chinese Medical Treatment on Leucopenia After Chemotherapy in Breast Cancer Patients

NCT01359501 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a two-year double blind, placebo-controlled, and randomized clinical trial, which is aimed to evaluate the effects of Chinese medical treatment on leucopenia after chemotherapy in breast cancer patients.

Timeline

Start
2011-05
Primary completion
2012-12
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject LCH1 Traditional medicine (herbal / TCM) 3 g —